Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Paul German Insider Profile
4 Followers
Christopher Paul German, Corporate Controller & CAO at Rhythm Pharmaceuticals, holds 795.00 shares in Rhythm Pharmaceuticals (Ticker: RYTM).
Christopher Paul German has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Paul German's holdings
Insider Roles
Corporate Controller & CAO
Roles that Christopher Paul German holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher Paul German
Christopher Paul German's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Paul German's performance on stock
You May Also Like
Christopher Paul German insider profile FAQ
What is the percentage of profitable transactions made by Christopher Paul German?
The percentage of profitable transactions made by Christopher Paul German is ―.
What is the average return per transaction made by Christopher Paul German?
The average return per transaction made by Christopher Paul German is ―.
What stocks does Christopher Paul German hold?
Christopher Paul German holds: RYTM stocks.
What was Christopher Paul German’s latest transaction?
Christopher Paul German latest transaction was an Uninformative Sell of $15.37K.
What was Christopher Paul German's most profitable transaction?
Christopher Paul German’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Paul German's role in Rhythm Pharmaceuticals?
Christopher Paul German's role in Rhythm Pharmaceuticals is Corporate Controller & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.